Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicity. 2005

Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
Institut de Chimie Organique et Analytique, ICOA UMR 6005, UFR Sciences, BP 6759, 45067 Orléans Cedex 2, France.

In this article, we report the synthesis of hitherto unknown 5-haloethynyl and 5-(1,2-dihalo)vinyluracil nucleosides in the 2'-deoxy, 3'-deoxy- and ribosyl series, and we discuss their in vitro anti-HIV and anti-HCV activities and cellular toxicitites. As a result, on the basis of their selectivity index (SI) obtained with the HCV replicon system, but also on their cytotoxicity on peripheral blood mononuclear, CEM and VERO cell lines, the best compounds were the 5-bromoethynyluridine (SI = 3.2) and the 5-(1-chloro-2-iodo)vinyluridine (SI > 2.8).

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
May 2008, Tetrahedron,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
January 1989, Archiv der Pharmazie,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
February 1983, Journal of medicinal chemistry,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
September 2002, European journal of medicinal chemistry,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
December 1975, Biochemical pharmacology,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
October 2000, Journal of medicinal chemistry,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
January 1984, Acta biochimica Polonica,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
January 2004, Organic & biomolecular chemistry,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
June 1998, Archives of pharmacal research,
Vanessa Escuret, and Vincent Aucagne, and Nicolas Joubert, and David Durantel, and Kimberly L Rapp, and Raymond F Schinazi, and Fabien Zoulim, and Luigi A Agrofoglio
August 2004, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!